Ryota Nishimori
President bei CAC HOLDINGS CORPORATION
Vermögen: 623 212 $ am 31.03.2024
Profil
Ryota Nishimori is currently the President & Representative Director at CAC Holdings Corp.
since 2021 and the President & Representative Director at CAC Corp.
(Japanese) since 2014.
He previously served as the President & Director at CAC America Corp.
Bekannte Unternehmensbeteiligungen
Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
---|---|---|---|---|
CAC HOLDINGS CORPORATION
0,23% | 31.12.2022 | 48 000 ( 0,23% ) | 623 212 $ | 31.03.2024 |
Aktive Positionen von Ryota Nishimori
Unternehmen | Position | Beginn |
---|---|---|
CAC HOLDINGS CORPORATION | President | 01.01.2021 |
CAC KK
CAC KK Information Technology ServicesTechnology Services Part of CAC Holdings Corp., CAC Corp. (TY) is a Japanese company that supports all operations related to donations, significantly reducing time and effort while ensuring high transparency and safety. The private company is based in Tokyo, Japan. With standard functions, it can handle various types of applications, such as scholarships, general donations, academic society donations, research and development expenses, and donation applications from patient groups. Astellas Pharma, Novo Pharma, and several other pharmaceutical and medical device manufacturers have introduced this company. Founded in 2014. | President | 01.04.2014 |
Ehemalige bekannte Positionen von Ryota Nishimori
Unternehmen | Position | Ende |
---|---|---|
CAC America Corp. | President | - |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
Börsennotierte Unternehmen | 1 |
---|---|
CAC HOLDINGS CORPORATION | Technology Services |
Private Unternehmen | 2 |
---|---|
CAC America Corp. | |
CAC KK
CAC KK Information Technology ServicesTechnology Services Part of CAC Holdings Corp., CAC Corp. (TY) is a Japanese company that supports all operations related to donations, significantly reducing time and effort while ensuring high transparency and safety. The private company is based in Tokyo, Japan. With standard functions, it can handle various types of applications, such as scholarships, general donations, academic society donations, research and development expenses, and donation applications from patient groups. Astellas Pharma, Novo Pharma, and several other pharmaceutical and medical device manufacturers have introduced this company. Founded in 2014. | Technology Services |